In particular, IL37 could be detected in 1 clinically isolated syndrome (CIS) patient (concentration: 616.953 pg/mL) in 8 out of the 95 RR-MS patients (one sample was lost due to technical reasons) and in 2 out of 8 secondary progressive MS (SP-MS) patients. The gene discussed is IL37; the disease is in situ carcinoma.